BBHC
IDXX icon

Brown Brothers Harriman & Co’s Idexx Laboratories IDXX Stock Holding History

Brown Brothers Harriman & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Sell
2,162
-16
-0.7% -$8.97K 0.01% 476
2026
Q1 		$1.22M Buy
2,178
+892
+69% +$572K 0.01% 388
2025
Q4 		$870K Buy
1,286
+211
+20% +$144K ﹤0.01% 402
2025
Q3 		$687K Buy
1,075
+109
+11% +$66.2K ﹤0.01% 419
2025
Q2 		$518K Buy
966
+248
+35% +$119K ﹤0.01% 452
2025
Q1 		$302K Sell
718
-16
-2% -$6.95K ﹤0.01% 484
2024
Q4 		$303K Sell
734
-9
-1% -$3.95K ﹤0.01% 500
2024
Q3 		$375K Buy
743
+31
+4% +$15.1K ﹤0.01% 462
2024
Q2 		$347K Buy
712
+16
+2% +$8.03K ﹤0.01% 434
2024
Q1 		$376K Sell
696
-6
-0.9% -$3.28K ﹤0.01% 403
2023
Q4 		$390K Sell
702
-20
-3% -$9.39K ﹤0.01% 391
2023
Q3 		$316K Sell
722
-4
-0.6% -$2K ﹤0.01% 408
2023
Q2 		$365K Sell
726
-391
-35% -$187K ﹤0.01% 370
2023
Q1 		$559K Buy
1,117
+218
+24% +$104K ﹤0.01% 326
2022
Q4 		$367K Buy
899
+734
+445% +$285K ﹤0.01% 360
2022
Q3 		$54K Hold
165
– – ﹤0.01% 722
2022
Q2 		$58K Buy
165
+19
+13% +$7.75K ﹤0.01% 677
2022
Q1 		$80K Sell
146
-92
-39% -$48.4K ﹤0.01% 667
2021
Q4 		$157K Hold
238
– – ﹤0.01% 525
2021
Q3 		$148K Hold
238
– – ﹤0.01% 508
2021
Q2 		$150K Sell
238
-41
-15% -$22.6K ﹤0.01% 491
2021
Q1 		$137K Buy
279
+19
+7% +$9.52K ﹤0.01% 477
2020
Q4 		$130K Sell
260
-2
-0.8% -$895 ﹤0.01% 512
2020
Q3 		$103K Hold
262
– – ﹤0.01% 486
2020
Q2 		$87K Buy
262
+16
+7% +$4.63K ﹤0.01% 505
2020
Q1 		$60K Buy
246
+9
+4% +$2.35K ﹤0.01% 510
2019
Q4 		$62K Hold
237
– – ﹤0.01% 627
2019
Q3 		$64K Buy
237
+11
+5% +$3.06K ﹤0.01% 607
2019
Q2 		$62K Buy
226
+12
+6% +$2.96K ﹤0.01% 555
2019
Q1 		$48K Hold
214
– – ﹤0.01% 585
2018
Q4 		$40K Buy
+214
New +$43.9K ﹤0.01% 540
2018
Q2 		– Sell
-2,216
Closed -$424K – 835
2018
Q1 		$424K Hold
2,216
– – ﹤0.01% 258
2017
Q4 		$347K Sell
2,216
-120
-5% -$18.9K ﹤0.01% 277
2017
Q3 		$363K Sell
2,336
-1,000
-30% -$158K ﹤0.01% 261
2017
Q2 		$538K Sell
3,336
-965
-22% -$157K ﹤0.01% 221
2017
Q1 		$665K Buy
4,301
+227
+6% +$31.3K ﹤0.01% 207
2016
Q4 		$478K Sell
4,074
-532
-12% -$60.7K ﹤0.01% 215
2016
Q3 		$519K Hold
4,606
– – ﹤0.01% 214
2016
Q2 		$428K Buy
4,606
+3,693
+404% +$317K ﹤0.01% 243
2016
Q1 		$72K Buy
913
+123
+16% +$8.86K ﹤0.01% 400
2015
Q4 		$58K Hold
790
– – ﹤0.01% 447
2015
Q3 		$59K Buy
790
+400
+103% +$28.6K ﹤0.01% 471
2015
Q2 		$25K Buy
+390
New +$27K ﹤0.01% 584
2015
Q1 		– Sell
-566
Closed -$42K – 797
2014
Q4 		$42K Buy
+566
New +$39.7K ﹤0.01% 538
2014
Q1 		– Sell
-24,960
Closed -$1.33M – 803
2013
Q4 		$1.33M Buy
24,960
+12,480
+100% +$657K ﹤0.01% 217
2013
Q3 		$622K Sell
12,480
-3,050
-20% -$147K ﹤0.01% 210
2013
Q2 		$696K Buy
+15,530
New +$679K ﹤0.01% 248

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Brown Brothers Harriman & Co's IDXX Position: Q2 2026 in Review

Brown Brothers Harriman & Co reduced its Idexx Laboratories (IDXX) stake by 0.73% in Q2 2026, selling an estimated $8.97K and leaving 2,162 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #476.

Brown Brothers Harriman & Co first reported a position in IDXX in Q2 2013 and has held it in 47 quarters since. The position peaked at $1.33M in Q4 2013. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Brown Brothers Harriman & Co held 2,162 shares of Idexx Laboratories worth $1.14M as of Q2 2026.
  • Brown Brothers Harriman & Co sold 16 Idexx Laboratories shares in Q2 2026, an estimated $8.97K.
  • Idexx Laboratories made up 0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #476 holding.
  • Brown Brothers Harriman & Co first reported a position in Idexx Laboratories in Q2 2013 and has held it in 47 quarters since.
  • Brown Brothers Harriman & Co's Idexx Laboratories position peaked at $1.33M in Q4 2013.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.